Matt Thompson

Dr. Matt Thompson has been serving as Endologix’ Chief Medical Officer (CMO) since 2016. In November 2021, Dr. Thompson was appointed President and Chief Executive Officer of Endologix LLC. As CMO Dr. Thompson had oversight of the Company’s business development, medical affairs, regulatory, clinical and R&D departments. Dr. Thompson also led the April 2021 acquisition and subsequent integration of PQ Bypass.

He is also a contract Staff Surgeon, Department of Vascular Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation Ohio, and Visiting Professor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Previously he was the Professor of Vascular Surgery at St George’s, University of London and a Consultant Vascular Surgeon at St George’s Vascular Institute. Dr. Thompson trained at Cambridge, St Bartholomew’s Hospital, the University of Leicester and Adelaide. He studied corporate innovation at Stanford University, Graduate School of Business. His awards include a Hunterian Professorship, the Moynihan travelling fellowship and the gold medal for the intercollegiate examination. His named lectures include the Kinmonth Lecture (Vascular Society Great Britain and Ireland), the British Journal of Surgery Lecture (Vascular Society Great Britain and Ireland), and the Chee Song Memorial Lecture (British Society of Endovascular Therapy). He has published over 400 peer reviewed articles and his H-index is 101 (2020).

His clinical interests are in the treatment of aortic disease and endovascular surgery. His research interests include health service outcome research, clinical trials and translational investigations into aortic disease. Dr. Thompson is the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery.

He has been the clinical director for three London-wide service reconfigurations (cardiovascular disease, major trauma and emergency services). He was Chair of the National Specialized Commissioning Clinical Reference Group for Vascular Services. He is a founder of the British Society for Endovascular Therapy, a past Council Member of the Vascular Society, was Chairman of the Vascular Society Annual Scientific Meeting and was awarded a Lifetime Achievement Award by the Vascular Society of Great Britain and Ireland in 2017.